aTYR PHARMA INC
ATYR- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001339970
No open-market purchases or sales by aTYR PHARMA INC insiders were filed in the last 90 days; 89 institutions reported holding it in 13F filings for Q2 2026, worth $23.2M in total; no superinvestor holds it.
Q2 2023 vs. Q1 2023
How the institutions holding aTYR PHARMA INC changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 37 | 41 | +4 |
| Shares | 34.7M | 35.7M | +1.00M (+2.9%) |
| Value | $72.8M | $77.0M | +$4.25M (+5.8%) |
New holders (12)
Institutions that held aTYR PHARMA INC at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Millennium Management LLC | 352,104 | $760.5K | 0.00% |
| Man Group plc | 306,950 | $663.0K | 0.00% |
| XTX Topco Ltd | 170,425 | $368.1K | 0.07% |
| Susquehanna International Group, LLP | 46,634 | $100.7K | 0.00% |
| Vontobel Holding Ltd. | 30,000 | $64.8K | 0.00% |
| American Century Companies Inc | 14,191 | $30.7K | 0.00% |
| Two Sigma Securities, LLC | 12,001 | $25.9K | 0.00% |
| Schonfeld Strategic Advisors LLC | 11,100 | $24.0K | 0.00% |
| Alterna Wealth Management, Inc | 10,000 | $21.6K | 0.03% |
| Bank of America Corp | 1,483 | $3.20K | 0.00% |
| ICA Group Wealth Management, LLC | 75 | $162 | 0.00% |
| Caldwell Sutter Capital, Inc. | 52 | $112 | 0.00% |
Sold out (8)
Institutions that held aTYR PHARMA INC at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Samsara BioCapital, LLC | 1,750,000 | $3.67M |
| CVI Holdings, LLC | 588,571 | $1.24M |
| Salem Investment Counselors Inc | 40,000 | $84.0K |
| Ensign Peak Advisors, Inc | 37,884 | $79.6K |
| Marshall Wace, LLP | 10,947 | $23.0K |
| Tocqueville Asset Management L.P. | 10,150 | $21.3K |
| UBS Group AG | 1,000 | $2.10K |
| Raleigh Capital Management Inc. | 13 | $27 |